Category
Alfuzosin
CAS Number
98902-34-2
Molecular Formula
C₁₉H₂₇N₅O₄
Molecular Weight
389.45 g/mol
Synonym

(2RS)-N-[3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)amino]propyl]-N-methyltetrahydrofuran-2-carboxamide;N2-Methyl Alfuzosin;

Keywords
Fine Chemicals
Aromatics
Amines
Pharmaceutical Standards
Impurities
Heterocycles
Intermediates
High-Quality Pharmaceutical Reference Standards
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Manasa Life Sciences is a reliable manufacturer and supplier of high-quality Alfuzosin EP Impurity C (CAS No. 98902-34-2), chemically identified as (RS)-N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)amino]propyl]-N-methyltetrahydrofuran-2-carboxamide, with molecular formula C₁₉H₂₇N₅O₄ and molecular weight 389.45 g/mol. This pharmaceutical analytical reference standard is suitable for Alfuzosin impurity profiling, related-substance analysis, HPLC method development, analytical method validation, pharmaceutical quality control, and stability studies. Each batch undergoes comprehensive analytical characterization using HPLC, LC-MS, NMR, and IR spectroscopy to support identity, purity, and consistency. Manufactured under stringent quality-management practices and supported by GMP-aligned manufacturing and GDP-compliant handling, Alfuzosin EP Impurity C is supplied with essential documentation, including a Certificate of Analysis (CoA) and Safety Data Sheet (SDS/MSDS), to support pharmaceutical analytical testing, quality-control programs, and applicable USP, EP, USFDA, EMA, and ICH regulatory requirements.